Successful determination of imatinib dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction.
Keyword(s):
Imatinib is used as first-line treatment for chronic myeloid leukemia (CML) even in patients with impaired renal function. We successfully used therapeutic drug monitoring to determine the dose for re-administration of imatinib in a CML patient who initiated dialysis for acute renal dysfunction associated with the initial imatinib therapy.
2015 ◽
Vol 38
(5)
◽
pp. 645-654
◽
2012 ◽
Vol 34
(1)
◽
pp. 85-97
◽
2021 ◽
Vol 27
(8)
◽
pp. 1077-1085
2012 ◽
Vol 27
(6)
◽
pp. 690-697
◽